세계의 조직 진단 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)
Global Tissue Diagnostics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
상품코드:1676247
리서치사:Value Market Research
발행일:2025년 03월
페이지 정보:영문 145 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 조직 진단 시장 규모는 2024년 66억 4,000만 달러에서 2033년에는 144억 8,000만 달러로 성장하며, 2026-2033년의 예측 기간 중 9.04%의 견고한 연간 평균 성장률(CAGR)을 보일 것으로 예측됩니다.
조직진단 시장은 암 발병률 증가와 정확하고 시기적절한 진단 솔루션에 대한 수요 증가로 인해 크게 성장할 것으로 예상됩니다. 의료 서비스 프로바이더들이 조기 발견과 맞춤형 치료 계획을 통해 환자의 예후를 개선하기 위해 노력함에 따라 첨단 조직 진단 기술에 대한 수요가 급증하고 있습니다. 병리조직학, 면역조직화학, 분자진단 분야의 혁신은 조직 분석의 정확성과 효율성을 높여 의료 전문가가 환자 치료에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕고 있습니다. 디지털 병리학과 인공지능의 통합은 더 정확한 이미지 분석과 실험실 워크플로우 개선을 가능하게 하는 등 상황을 더욱 변화시키고 있습니다.
또한 맞춤형 의료가 강조되면서 조직 진단 시장에 영향을 미치고 있습니다. 암의 생물학적 이해도가 높아짐에 따라 다양한 암종과 관련된 특정 바이오마커를 식별할 수 있는 진단 검사에 대한 수요가 증가하고 있습니다. 이러한 추세는 치료 방침을 결정하고 치료 결과를 개선하는 데 도움이 되는 동반 진단의 개발을 촉진하고 있습니다. 또한 종양학 연구 및 개발에 대한 관심이 높아지면서 조직 진단의 기술 혁신을 촉진하고 진단 능력을 향상시키는 새로운 분석 및 기술 도입으로 이어지고 있습니다.
또한 암 검진 및 진단을 개선하기 위한 인식 개선 캠페인과 구상 증가는 조직 진단 시장의 성장에 기여하고 있습니다. 조기 발견의 중요성에 대한 환자들의 인식이 높아짐에 따라 신뢰할 수 있고 사용하기 쉬운 진단 솔루션에 대한 수요가 증가할 것으로 예상됩니다. 또한 학계, 연구기관, 산업계의 협력은 조직 진단의 발전을 촉진하고 있으며, 새로운 기술이 의료진과 환자의 진화하는 요구에 부응할 수 있도록 돕고 있습니다.
당사의 보고서는 고객에게 다양한 산업 및 시장에 대한 종합적이고 실용적인 인사이트를 제공하기 위해 세심하게 작성되었습니다. 각 보고서는 시장 상황을 완전히 이해하기 위해 몇 가지 중요한 요소를 포함하고 있습니다.
시장 개요 : 시장 개요 : 정의, 분류, 산업 현황 등 시장에 대한 자세한 소개.
시장 성장 촉진요인: 시장 성장에 영향을 미치는 주요 촉진요인, 억제요인, 시장 성장 촉진요인 및 과제를 상세하게 분석합니다. 이 섹션에서는 기술 발전, 규제 변화, 새로운 동향 등의 요인을 검토합니다.
세분화 분석 : 제품 유형, 애플리케이션, 최종사용자, 지역 등의 기준에 따라 시장을 명확한 부문으로 분류합니다. 이 분석을 통해 각 부문의 성과와 잠재력을 파악할 수 있습니다.
경쟁상황: 시장 점유율, 제품 포트폴리오, 전략적 구상, 재무실적 등 주요 시장 진입기업에 대한 종합적인 평가. 주요 기업이 채택하고 있는 경쟁 역학 및 주요 전략에 대한 인사이트이 포함되어 있습니다.
시장 예측 : 과거 데이터와 현재 시장 상황을 바탕으로 일정 기간 중 시장 규모와 성장 추세를 예측합니다. 여기에는 정량적 분석과 미래 시장 궤적을 나타내는 그래프 표시가 포함됩니다.
지역 분석 : 지역별 시장 성과를 평가하고 주요 시장 및 지역 동향을 파악할 수 있습니다. 지역 시장 역학 및 비즈니스 기회를 이해하는 데 도움이 됩니다.
새로운 동향과 기회: 현재 시장 동향과 새로운 시장 동향, 기술 혁신, 잠재적 투자 대상 부문을 식별합니다. 미래 시장 개발 및 성장 전망에 대한 인사이트를 제공합니다.
목차
제1장 서문
제2장 개요
시장의 하이라이트
세계 시장 스냅숏
제3장 조직 진단 산업 분석
서론 : 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
산업 동향
Porter's Five Forces 분석
시장의 매력 분석
제4장 밸류체인 분석
밸류체인 분석
원료 분석
원료 리스트
원료 제조업체 리스트
주요 원료의 가격 동향
잠재적 바이어 리스트
마케팅 채널
직접 마케팅
간접 마케팅
마케팅 채널 발전 동향
제5장 세계의 조직 진단 시장 분석 : 제품별
제품별 개요
제품별 과거·예측 데이터 분석
소모품(항체, 키트, 시약, 프로브)
기기(슬라이드 염색 시스템, 스캐너, 조직 처리 시스템, 기타 기기(자동 커버 슬리퍼, 마이크로톰, 임베딩 시스템, 파라핀 디스펜서, 슬라이드 라벨러))
Global Tissue Diagnostics Market size is anticipated to grow from USD 6.64 Billion in 2024 to USD 14.48 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 9.04% during the forecast period of 2026 to 2033.
The tissue diagnostics market is poised for significant growth, driven by the increasing prevalence of cancer and the rising demand for accurate and timely diagnostic solutions. As healthcare providers seek to improve patient outcomes through early detection and personalized treatment plans, the need for advanced tissue diagnostic technologies is surging. Innovations in histopathology, immunohistochemistry, and molecular diagnostics are enhancing the accuracy and efficiency of tissue analysis, enabling healthcare professionals to make informed decisions regarding patient care. The integration of digital pathology and artificial intelligence is further transforming the landscape, allowing for more precise image analysis and improved workflow in laboratories.
Moreover, the growing emphasis on personalized medicine is influencing the tissue diagnostics market. As the understanding of cancer biology advances, there is a rising demand for diagnostic tests that can identify specific biomarkers associated with different cancer types. This trend is driving the development of companion diagnostics that guide treatment decisions and improve therapeutic outcomes. Additionally, the increasing focus on research and development in oncology is fostering innovation in tissue diagnostics, leading to the introduction of novel assays and technologies that enhance diagnostic capabilities.
Furthermore, the rise of awareness campaigns and initiatives aimed at improving cancer screening and diagnosis is contributing to the growth of the tissue diagnostics market. As patients become more informed about the importance of early detection, the demand for reliable and accessible diagnostic solutions is expected to rise. Collaborations between academic institutions, research organizations, and industry players are also driving advancements in tissue diagnostics, ensuring that new technologies meet the evolving needs of healthcare providers and patients.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
SEGMENTATION COVERED IN THE REPORT
By Product
Consumables
Antibodies
Kits
Reagents
Probes
Instruments
Slide-staining Systems
Scanners
Tissue-processing Systems
Other Instruments (automated cover slippers, microtomes, embedding systems, paraffin dispensers, and slide labelers)
By Technology
Immunohistochemistry
In Situ Hybridization
Digital Pathology & Workflow Management
Special Staining
By Disease Type
Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-small Cell Lung Cancer
Other Disease Types (neurological disease, cardiovascular disease, immunological diseases, infectious diseases, cancers of the bone, colon, thyroid, cervix, and skin; gallbladder carcinoma; HBV; Epstein-Barr virus; hepatitis; muscular dystrophy; renal cell carcinoma; and pleomorphic sarcomas.)
By End User
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations (CROs)
Other End Users (reference laboratories and academic research laboratories)
3.7.2 Market Attractiveness Analysis By Technology
3.7.3 Market Attractiveness Analysis By Disease Type
3.7.4 Market Attractiveness Analysis By End User
3.7.5 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT
5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Consumables (Antibodies, Kits, Reagents, Probes) Historic and Forecast Sales By Regions
5.4. Instruments(Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments (Automated Cover Slippers, Microtomes, Embedding Systems, Paraffin Dispensers, And Slide Labelers)) Historic and Forecast Sales By Regions
6. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. Immunohistochemistry Historic and Forecast Sales By Regions
6.4. In Situ Hybridization Historic and Forecast Sales By Regions
6.5. Digital Pathology & Workflow Management Historic and Forecast Sales By Regions
6.6. Special Staining Historic and Forecast Sales By Regions
7. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY DISEASE TYPE
7.1. Overview By Disease Type
7.2. Historical and Forecast Data Analysis By Disease Type
7.3. Breast Cancer Historic and Forecast Sales By Regions
7.4. Gastric Cancer Historic and Forecast Sales By Regions
7.5. Lymphoma Historic and Forecast Sales By Regions
7.6. Prostate Cancer Historic and Forecast Sales By Regions
7.7. Non-small Cell Lung Cancer Historic and Forecast Sales By Regions
7.8. Other Disease Types (Neurological Disease, Cardiovascular Disease, Immunological Diseases, Infectious Diseases, Cancers Of The Bone, Colon, Thyroid, Cervix, And Skin, Gallbladder Carcinoma, Hbv, Epstein-Barr Virus, Hepatitis, Muscular Dystrophy, Renal Cell Carcinoma, And Pleomorphic Sarcomas.) Historic and Forecast Sales By Regions
8. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY END USER
8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Research Laboratories Historic and Forecast Sales By Regions
8.5. Pharmaceutical Companies Historic and Forecast Sales By Regions
8.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
8.7. Other End Users (Reference Laboratories And Academic Research Laboratories) Historic and Forecast Sales By Regions
9. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
9.3.1 Overview, Historic and Forecast Data Sales Analysis
9.3.2 North America By Segment Sales Analysis
9.3.3 North America By Country Sales Analysis
9.3.4 United States Sales Analysis
9.3.5 Canada Sales Analysis
9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1 Overview, Historic and Forecast Data Sales Analysis
9.4.2 Europe By Segment Sales Analysis
9.4.3 Europe By Country Sales Analysis
9.4.4 United Kingdom Sales Analysis
9.4.5 France Sales Analysis
9.4.6 Germany Sales Analysis
9.4.7 Italy Sales Analysis
9.4.8 Russia Sales Analysis
9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1 Overview, Historic and Forecast Data Sales Analysis
9.5.2 Asia Pacific By Segment Sales Analysis
9.5.3 Asia Pacific By Country Sales Analysis
9.5.4 China Sales Analysis
9.5.5 India Sales Analysis
9.5.6 Japan Sales Analysis
9.5.7 South Korea Sales Analysis
9.5.8 Australia Sales Analysis
9.5.9 South East Asia Sales Analysis
9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1 Overview, Historic and Forecast Data Sales Analysis
9.6.2 Latin America By Segment Sales Analysis
9.6.3 Latin America By Country Sales Analysis
9.6.4 Brazil Sales Analysis
9.6.5 Argentina Sales Analysis
9.6.6 Peru Sales Analysis
9.6.7 Chile Sales Analysis
9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1 Overview, Historic and Forecast Data Sales Analysis
9.7.2 Middle East & Africa By Segment Sales Analysis
9.7.3 Middle East & Africa By Country Sales Analysis
9.7.4 Saudi Arabia Sales Analysis
9.7.5 UAE Sales Analysis
9.7.6 Israel Sales Analysis
9.7.7 South Africa Sales Analysis
9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE TISSUE DIAGNOSTICS COMPANIES
10.1. Tissue Diagnostics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11. COMPANY PROFILES OF TISSUE DIAGNOSTICS INDUSTRY
11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. F. Hoffmann-La Roche Ltd
11.3.1 Company Overview
11.3.2 Company Revenue
11.3.3 Products
11.3.4 Recent Developments
11.4. Danaher Corporation
11.4.1 Company Overview
11.4.2 Company Revenue
11.4.3 Products
11.4.4 Recent Developments
11.5. PHC Holdings Corporation
11.5.1 Company Overview
11.5.2 Company Revenue
11.5.3 Products
11.5.4 Recent Developments
11.6. Agilent Technologies Inc.
11.6.1 Company Overview
11.6.2 Company Revenue
11.6.3 Products
11.6.4 Recent Developments
11.7. Thermo Fisher Scientific Inc.
11.7.1 Company Overview
11.7.2 Company Revenue
11.7.3 Products
11.7.4 Recent Developments
11.8. Abbott Laboratories
11.8.1 Company Overview
11.8.2 Company Revenue
11.8.3 Products
11.8.4 Recent Developments
11.9. GE Healthcare
11.9.1 Company Overview
11.9.2 Company Revenue
11.9.3 Products
11.9.4 Recent Developments
11.10. Cell Signaling Technology Inc.
11.10.1 Company Overview
11.10.2 Company Revenue
11.10.3 Products
11.10.4 Recent Developments
11.11. BioGenex
11.11.1 Company Overview
11.11.2 Company Revenue
11.11.3 Products
11.11.4 Recent Developments
11.12. Siemens
11.12.1 Company Overview
11.12.2 Company Revenue
11.12.3 Products
11.12.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
